Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 459  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Article Submission Resources Sections Etcetera Contact
 
  NAVIGATE Here 
  Search
 
 :: Next article
 :: Previous article 
 :: Table of Contents
  
 RESOURCE Links
 ::  Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::Related articles
 ::  Article in PDF (963 KB)
 ::  Citation Manager
 ::  Access Statistics
 ::  Reader Comments
 ::  Email Alert *
 ::  Add to My List *
* Registration required (free) 

  IN THIS Article
 ::  Abstract
 ::  Patient and methods
 ::  Results
 ::  Discussion
 ::  References
 ::  Article Figures
 ::  Article Tables

 Article Access Statistics
    Viewed11041    
    Printed240    
    Emailed12    
    PDF Downloaded288    
    Comments [Add]    
    Cited by others 13    

Recommend this journal


 


 
BRIEF REPORTS
Year : 2003  |  Volume : 49  |  Issue : 1  |  Page : 25-8

Malignant tumours of the minor salivary glands: a survival analysis of 17 years from a tertiary referral cancer centre.


Department of Surgical Oncology, Regional Cancer Centre, Medical College P.O. Thiruvananthapuram - 695 011, India. , India

Correspondence Address:
M Pandey
Department of Surgical Oncology, Regional Cancer Centre, Medical College P.O. Thiruvananthapuram - 695 011, India.
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0022-3859.932

Rights and Permissions


 :: Abstract 

BACKGROUND: Malignant tumours of the minor salivary glands are rare and constitute less than 0.5% of all malignant neoplasms. AIM: This study was carried out to evaluate the clinical presentation, site distribution, treatment, survival and predictors of survival in malignant minor salivary gland tumours. SETTING: A tertiary care, superspeciality referral hospital. DESIGN: Retrospective analysis. PATIENTS AND METHOD: Forty-two cases of minor salivary gland tumours treated over a period of 17 years were reviewed for clinical presentation, histopathology, stage distribution, treatment and treatment outcome. STATISTICAL ANALYSIS: Survival by Kaplan Meier Method and the outcomes were compared using log-rank test. RESULTS: The mean age of the patients was 46.9 years with a male to female ratio of 1.4:1. Majority of the patients presented with a painless progressive swelling, with 13 (31%) of them in T2 stage. About one-third of the patients had palpable lymph nodes at presentation, while none had distant metastasis. Palate was the commonest site and mucoepidermoid carcinoma was the commonest hispathological type. About 1/3 of the patients were treated with primary surgery and were followed up by adjuvant radiotherapy. Seven patients underwent palliative treatment alone. Over a mean follow-up of 30 months, 5 patients failed. The disease free survival was 72% at 5-year, none of the factors studied were found to significantly influence survival. CONCLUSIONS: Results of the present study suggest that minor salivary gland tumours should be treated with primary surgery irrespective of site and histological type to achieve best loco-regional control and survival.


Keywords: Adolescent, Adult, Aged, Carcinoma, diagnosis,pathology,therapy,Disease-Free Survival, Female, Human, Male, Middle Age, Neoplasm Staging, Palate, pathology,Retrospective Studies, Salivary Gland Neoplasms, diagnosis,pathology,therapy,Survival Analysis, Treatment Outcome,


How to cite this article:
Pandey M, Thomas S, Mathew A, Nair M K. Malignant tumours of the minor salivary glands: a survival analysis of 17 years from a tertiary referral cancer centre. J Postgrad Med 2003;49:25

How to cite this URL:
Pandey M, Thomas S, Mathew A, Nair M K. Malignant tumours of the minor salivary glands: a survival analysis of 17 years from a tertiary referral cancer centre. J Postgrad Med [serial online] 2003 [cited 2019 Jul 21];49:25. Available from: http://www.jpgmonline.com/text.asp?2003/49/1/25/932


Tumours of salivary gland constitute a heterogeneous group of neoplasms originating from the proliferation of different precursor cells.[1] They represent about 3-5% of all head and neck neoplasms with incidence of malignancy varying with primary site of origin.[2],[3],[4],[5] Most of these tumours arise in major salivary glands. Malignant neoplasm of minor salivary glands constitutes 9-20% in various series.[5],[6],[7],[8],[9],[10] Malignant tumors of minor salivary glands are rare and constitute less than 0.5% of all malignant neoplasms. Majority of the earlier series concentrated on histopathological type and epidemiological distribution of the disease. Due to the rarity of the disease, and cases in series being treated over many years by differing modalities of treatment there is no consensus on what should be the optimal treatment. A few studies concentrating on prognostic factors have found the histological type, tumour grade, localisation of tumour and stage as important prognostic factors.[11],[12],[13] In the present study we describe our experience with 42 cases of malignant tumours of minor salivary gland treated at our centre.


  ::   Patient and methods Top


All cases of malignant tumours minor salivary gland treated at our centre between 1982-1999 were extracted from the electronic database of Regional Cancer Centre, Trivandrum, India, maintained on Ingress software (Ingress corp., California USA) by using International Classification of Diseases- Oncology (ICD-O) (1st edition) codes for histology and sites. A total of 42 patients were identified. The case records of these patients were reviewed for history, clinical findings, pathological types, treatment and outcome details. All the patients were staged using International Union Against Cancer (UICC), Tumour, Node, and Metastasis (TNM) classification (1997).14 Survival analysis was carried out using Kaplan-Meier method and the curves were compared using long-rank test.


  ::   Results Top


A total of 42 patients treated between 1982-1999 were included, this constituted about 0.001% of all head and neck cancers seen during the same period. The mean age of the patients was 46.9 years [standard deviation (SD) + 16.7] ranging from 14 years to 76 years, with a male to female ratio of 1.4:1. There were 14 (33.3%) Christians, 21 (50%) Hindus and 6 (14.3%) Muslims. Past history of chewing tobacco was present in one (2.4%), alcoholism in two (4.8%), and smoking in 2 (4.8%) patients. None of the patients had a family history of tumours of salivary gland and only one (2.4%) had a family history of other cancers.

Progressive painless swelling was the commonest presenting feature in 22 (52.4%) patients, five (11.9%) patients had pain while 4 (9.5%) presented with ulcerated lesion. There were 8 (19%) cases of T1, 13 (31%) of T2, 7 (16.7%) of T3 and 3 (7.1%) cases of T4 tumour. The T stage of primary tumour was not known (Tx) in 11 (26.2%) patients [Table - 1].

Clinically palpable nodes were present in 14 (33.3%) patients, this was N1 in 9 (21.4%), N2 in 4 (9.5%) and N3 in 1 (2.4%). Majority of the lesions (7; 16.7%) were present on hard palate followed by tongue and nasopharynx (5 each; 11.9%) [Table - 1]. Almost half of the tumours were mucoepidermoid carcinoma (19; 45.2%) followed by adenoid cystic carcinoma in 9 (21.4%), adenocarcinoma not otherwise specified in 7 (16.7%) and mucin producing adenocarcinoma in 5 (11.9%).

Majority of the patients were treated by surgery as primary modality and were followed by radiotherapy (13; 31%). Nine (21.4%) were treated by surgery alone while 7 (16.7%) underwent radiotherapy alone. Seventeen patients underwent neck dissection, of these one underwent radical neck dissection; 3 underwent modified radical neck dissection; 4 underwent selective neck dissection while 9 underwent bilateral neck dissection, which was modified radical on ipsilateral side and selective on contra lateral side. The intention of treatment was palliative in 7 patients. The details of treatment are given in [Table - 2]. Of the 11 patients treated by primary radiotherapy only 4 had complete response while 4 (9.6%) had residual disease in primary and 3 (7.2%) had residual disease in both primary and neck. One patient treated by radiotherapy and chemotherapy had complete response. All patients with partial or no response were managed by salvage surgery. After a mean follow-up of 30 months (median follow-up of 19 months; range 1-144 months), five patients failed the pattern of treatment failure is detailed in [Table - 2]. Of these, one patient was salvaged by surgery, two by radiotherapy while one patient received palliative treatment alone. The disease free survival at 5-years was 72% (median 72 months) [Figure - 1]. None of the factors studied were found to have a significant effect on survival [Table - 3] [Figures:2] & [Figure - 3].


  ::   Discussion Top


Tumours arising in the minor salivary gland are rare. They occur at almost all age with slight female preponderance and preferred location being palate.[2],[15] However, the present study showed a slight male preponderance. The tumours have diverse histopathology and are classified as epithelial, non-epithelial, lymphomas and unclassified tumours. Malignant epithelial tumours are further classified in about 18 sub types. This paper describes our experience with malignant tumours of salivary gland of epithelial origin. Two of the patients undergoing primary surgery elsewhere remained unclassified.

Like various other series,[1],[2],[7],[8],[10] this study too is plagued by absence of a definite treatment protocol, the cases being treated over a long period of time. Seven patients were offered no treatment or palliative treatment alone at our centre. Cure rate were near 100% for those treated by surgery as primary modality with or without adjuvant radiotherapy. Results of primary radiotherapy were however poor with only 4/11 having a complete response to radiotherapy, two of these subsequently failed. On the other hand 2 out of 9 patients undergoing primary surgery and 1/13 patient undergoing surgery with adjuvant radiotherapy failed. A lower failure rate and higher survival in these neoplasms has also been reported by Lopes et al (1998).[1] Recent studies[16] using fast neutron therapy in adenoid cystic carcinoma however have shown a higher response to primary radiotherapy (5 year survival of 72%) which is similar to the present series. A even higher survival is however achieved by using radiotherapy as adjuvant after complete removal of tumour surgically.[17] Similar results were observed in the present study as well.

Survival rates were better among males (88.9% vs. 39.4%), and in low or intermediate grade tumours (80-100% vs. 50%). Survival was also better in Tx tumours (patients with previous surgical excision) (100% vs. 66.6%) and in node-negative patients (100% vs. 58.7%). None of these differences were however statistically significant. Similarly, none of the parameters studied in univariate analysis were found to be statistically significant.

Results of the present study shows that all patients with tumours of minor salivary gland should be treated by surgery primarily with adjuvant radiotherapy irrespective of site, or histopathological type to achieve good local control and overall survival.

 
 :: References Top

1.Lopes MA, Santos GC, Kowalski LP. Multivariate survival analysis of 128 cases of oral cavity minor salivary gland carcinomas. Head Neck 1998;20:699-706.  Back to cited text no. 1    
2.Loyola AM, deAraujo VC, deSousa SO, deAraujo NS. Minor salivary gland tumours. A retrospective study of 164 cases in a Brazilian population. Oral Oncol Eur J Cancer B Oral Oncol 1995;31B:197-201.   Back to cited text no. 2    
3.Matsuba HM, Thawley SE, Simpson JR, Levine LA, Mauney M. Adenoid cystic carcinoma of the major and minor salivary origin. Laryngoscope 1984;94:1316-8.   Back to cited text no. 3    
4.van der Wal JE, Snow GB, van der Waal. Histological reclassification of 101 internal salivary gland tumours (New WHO classification). J Clin Pathol 1992;45:834-35.   Back to cited text no. 4    
5.Eveson JW, Cawson RA. Salivary gland tumours: a review of 2410 cases with particular reference to histological type, site, age, and sex distribution. J Pathol 1985;146:51-8.   Back to cited text no. 5    
6.Gates GA. Current concepts in otolaryngology: Malignant neoplasms of the minor salivary gland. N Engl J Med 1982;306:718-22.   Back to cited text no. 6    
7.Eveson JW, Cawson RA. Tumours of the minor (oropharyngeal) salivary glands: a demographic study of 336 cases. J Oral Pathol 1985;14:500-9.   Back to cited text no. 7    
8.Waldron CA, EI-Mofty SK, Gneep DR. Tumours of the intra oral minor salivary glands a demographic and histological study of 426 cases. Oral Surg Oral Med Oral Pathol 1988;66:323-33.   Back to cited text no. 8    
9.Beckhardt RN, Weber RS, Zane R, Garden AS, Wolf P, Carsillo R, et al. Minor salivary gland tumours of the palate:Clinical and pathological correlates of the outcome. Laryngoscope 1995;105:1155-60.   Back to cited text no. 9    
10.Anderson JN Jr, Beenken SW, Crowe R, Soong SJ, Peters G, Maddox WA, et al. Prognostic factors in minor salivary gland tumours. Head Neck 1995;17:480-6.   Back to cited text no. 10    
11.Eneroth CM. Salivary gland tumours in the parotid gland, submandibular gland, and palate region. Cancer 1971;27:1415-8.   Back to cited text no. 11    
12.Hickman R, Cawson RA, Duffy SW. The prognosis of specific type of salivary gland tumours. Cancer 1984;54:1620-4.   Back to cited text no. 12    
13.Spiro RH, Hadju SI, Strong EW. Tumours of the sub maxillary gland. Am J Surg 1976;132:463-8.   Back to cited text no. 13    
14.Hermanek P, Hutter RVP, Sobin LH, Wagner G, Wittekind Ch. UICC TNM atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours. Fourth edn. Springer-Verlag, New York: 1999. pp. 59-63.   Back to cited text no. 14    
15.Regezi JA, Lloyd RV, Zarbo RI, McClatchey KD. Minor salivary gland tumours. A histologic and immunohistochemical study. Cancer 1985;55:108-115.   Back to cited text no. 15    
16.Douglas JG, Laramore GE, Austin-Seymour M, Koh WJ, Lindsley KL, Cho P, et al. Neutron radiotherapy for adenoid cystic carcinoma of minor salivary glands. Int J Radiat Oncol Biol Phys 1996;36:87-93.  Back to cited text no. 16    
17.Douglas JG, Laramore GE, Austin-Seymour M, Koh W, Stelzer K, Griffin TW. Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy. Int J Radiat Oncol Biol Phys 2000;46:551-57.  Back to cited text no. 17    


    Figures

[Figure - 1], [Figure - 2], [Figure - 3]

    Tables

[Table - 1], [Table - 2], [Table - 3]

This article has been cited by
1 125I brachytherapy alone for recurrent or locally advanced adenoid cystic carcinoma of the oral and maxillofacial region
M.-W. Huang,L. Zheng,S.-M. Liu,Y. Shi,J. Zhang,G.-Y. Yu,J.-G. Zhang
Strahlentherapie und Onkologie. 2013; 189(6): 502
[Pubmed] | [DOI]
2 Radioactive Seed Implantation Combined with Prosthesis Denture in Treatment of Oral and Maxillofacial Malignancy
Jian Meng,Qing-fei Meng,Qian-ping Gu,Ya-meng Si,Hao Zheng,Jie Zhang,Zhi-ping Li,Qian-wei Zhuang
Cell Biochemistry and Biophysics. 2013;
[Pubmed] | [DOI]
3 The frequency and distribution pattern of minor salivary gland tumors in a government dental teaching hospital, Chennai, India
Nandimandalam Venkata Vani,Irulandy Ponniah
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2011; 111(1): e32
[Pubmed] | [DOI]
4 A 10-Year Retrospective Study on Malignant Jaw Tumors in Iran :
Nasim Taghavi, Leili Mehrdad, Moones Rajabi, Alireza Akbarzadeh
Journal of Craniofacial Surgery. 2010; 21(6): 1816
[VIEW] | [DOI]
5 Use of propofol anesthesia and adjunctive treatment with levetiracetam and gabapentin in managing status epilepticus in a patient of acute intermittent porphyria
Rohit Bhatia,Deepti Vibha,M. V. Padma Srivastava,Kameshwar Prasad,Manjari Tripathi,Mamta Bhushan Singh
Epilepsia. 2008; 49(5): 934
[Pubmed] | [DOI]
6 Malignant tumors of the minor salivary glands in northern Pakistan
Bushra Rahman,Nadira Mamoon,Shahid Jamal,Nadia Zaib,Mohammad Luqman,Sajid Mushtaq,Masood Anwar
Hematology/Oncology and Stem Cell Therapy. 2008; 1(2): 90
[Pubmed] | [DOI]
7 Tumours of minor salivary glands. Retrospective study of 46 cases | [Tumores de glndulas salivales menores. Estudio retrospectivo de]
Ávila, R.E., Samar, M.E., Camps, D., Fernández, R., Fernández, J.E.
Revista Espanola de Patologia. 2008; 41(1): 23-29
[Pubmed]
8 Tumores de glándulas salivales menores. Estudio retrospectivo de 46 casos
Rodolfo Esteban Ávila,María Elena Samar,Diego Camps,René Fernández,Javier Elías Fernández
Revista Española de Patología. 2008; 41(1): 23
[Pubmed] | [DOI]
9 Treatment of seizures in the neurologic intensive care unit
Panayiotis N. Varelas,Marek Mirski
Current Treatment Options in Neurology. 2007; 9(2): 136
[Pubmed] | [DOI]
10 Management of Seizures in the Critically Ill
Panayiotis N. Varelas,Marianna Spanaki
The Neurologist. 2006; 12(3): 127
[Pubmed] | [DOI]
11 Reconstruction of the Palate Following Removal of Palatal Salivary Gland Tumors
Andrew E. Brown
Journal of Oral and Maxillofacial Surgery. 2005; 63(8): 4
[Pubmed] | [DOI]
12 Levetiracetam in Porphyric Status Epilepticus
Megdad M Zaatreh
Clinical Neuropharmacology. 2005; 28(5): 243
[Pubmed] | [DOI]
13 Management of seizures in critically ill patients
Panayiotis N. Varelas,Marek A. Mirski
Current Neurology and Neuroscience Reports. 2004; 4(6): 489
[Pubmed] | [DOI]



 

Top
Print this article  Email this article
Previous article Next article
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow